Zymtronix and ginkgo bioworks announce partnership to produce enzymes for the industrialization of cell-free biomanufacturing

Durham, n.c. and boston , feb. 16, 2023 /prnewswire/ -- zymtronix, a developer of cell-free process technologies, and ginkgo bioworks (nyse: dna), which is building the leading platform for cell programming and biosecurity, today announced a partnership to optimize enzymes used in zymtronix's proprietary cell-free platform for the production of important ingredients in food, agriculture, cosmetics and pharmaceuticals.
DNA Ratings Summary
DNA Quant Ranking